(a)Except for any obligations or covenants of the Company pursuant to this Release or the Separation Agreement and as otherwise expressly provided in this Release, Executive, for himself and his heirs, executors, administrators, assigns, successors and agents (collectively, the “Executive’s Affiliates”) hereby fully and without limitation releases and forever discharges the Company and any of its parents, direct or indirect subsidiaries, affiliates, divisions, or related entities (collectively referred to herein as the “Company and its Related Entities”), and each of their respective agents, representatives, shareholders, owners, officers, directors, employees, consultants, attorneys, auditors, accountants, investigators, affiliates, successors and assigns (collectively, the “Company Releasees”), both individually and collectively, from any and all rights, claims, demands, liabilities, actions, causes of action, damages, losses, costs, expenses and compensation, of whatever nature whatsoever, known or unknown, fixed or contingent, which Executive or any of Executive’s Affiliates has or may have or may claim to have against the Company Releasees by reason of any matter, cause, or thing whatsoever, from the beginning of time to the date that Executive signs this Release (“Claims”), including, but not limited to, all (i) Claims arising out of, or that might be considered to arise out of or to be connected in any way with his employment or other relationship with any of the Company Releasees, or the termination of such employment or other relationship; (ii) Claims under any contract, agreement, understanding, or compensation arrangement between Executive and any of the Company Releasees, whether written or oral, whether express or implied, (including, but not limited to, except as otherwise explicitly provided for in this Release, under Executive’s Offer Letter with the Company dated on or about October 24, 2023, Executive’s Severance Agreement with the Company dated on or about December 12, 2023, Executive’s Change in Control Agreement with the Company dated on or about December 12, 2023; the STAAR Surgical Company Amended and Restated Omnibus Equity Incentive Plan, as amended from time to time (the “Equity Plan”) and any and all Awards or Award Agreements thereunder (each as such term is defined in the Equity Plan), and the Cash Recognition and Retention Award by and between you and the Company, dated March 26, 2025); (iii) any Claims arising out of arising under any federal, state, foreign, or local law, rule, ordinance, or public policy, including, without limitation, (A) Claims for discrimination, harassment, or retaliation under any such law, including but not limited to the California Fair Employment and Housing Act, the California Family Rights Act, the California Labor Code, Section 1542 of the California Civil Code, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, 42 U.S.C. § 1981, the National Labor Relations Act and the Equal Pay Act, as the same may be amended from time to time, (B) Claims arising under the